Abstract
In a multicentric European survey,1 cephalosporins were responsible for 10% to 40% of β-lactam hypersensitivity reactions. Adverse reactions to ceftaroline, a broad-spectrum, fifth-generation parenteral cephalosporin, were reported in 10% to 20% of inpatients, a fifth of which were suspected hypersensitivity reactions.2 Establishing nonirritant concentrations (NICs) for skin tests (STs) is critical to ascertain the optimal balance of sensitivity and specificity, improve antibiotic stewardship for the patient, and reduce the costs of health systems.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of Allergy and Clinical Immunology: In Practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
